Mid-Year Weight Loss Check-In: Pivot or Persevere?

Half the year is gone. If you started a GLP-1 back in January, riding that New Year wave of motivation, you're sitting at a checkpoint right now whether you planned for one or not. Maybe the scale moved exactly the way you hoped. Maybe it stalled in April and hasn't budged since. Or maybe you've hit your goal and you're quietly wondering if you can stop now, pocket the win, and get on with your life. These are the conversations filling my schedule this time of year, and they're worth having out loud.

I'm Dr. Farhan Abdullah, and I run Magnolia Functional Wellness here in Southlake. I'm an internal medicine physician, so I spend a lot of my week in hospitals taking care of people whose weight quietly set the stage for a heart attack or a stroke years before they ever met me. That perspective shapes how I think about the mid-year weight loss check-in. This isn't really about a number on a scale. It's about whether the plan you're on still fits the body and the life you actually have in late June, and what you do when the answer is "not quite."

So let's do the assessment honestly. Pivot or persevere? The right call depends on where you are, and there are really only a handful of places you can be.

First, define what "on track" even means

Here's where a lot of people trip themselves up. They set a January goal of, say, fifty pounds, do the arithmetic of "I should be losing two pounds a week," and then panic in June because they're at twenty-five instead of fifty. That math was never realistic, and chasing it tends to make people miserable.

The clinical benchmark most of us use is simpler and kinder. If you've lost five percent of your starting body weight, you've already moved the needle on blood pressure, blood sugar, and triglycerides. Ten percent is where the bigger metabolic wins show up. The large semaglutide and tirzepatide trials weren't measuring people against some Instagram transformation. They were measuring percentages, and the percentages that mattered medically were often in that five to fifteen percent range over a year or more.

So before you decide you've failed, recalculate. Take your weight on January 1st, take your weight today, and figure out the percentage. A 220-pound person who's down to 198 has lost ten percent. That's not a stall. That's a clinically meaningful result that a cardiologist would be thrilled to see. Part of my job at this checkpoint is talking people out of disappointment they have no business feeling. What you weigh matters less than where you started and which direction you're heading.

And if you genuinely haven't moved at all? That's real information too, and it points toward a pivot rather than just gritting your teeth and waiting.

The plateau: when persevering is exactly right

The most common reason people want to bail in June is the plateau. The first three or four months felt almost effortless. The weight came off, the food noise went quiet, and then somewhere around month five the scale planted its feet and stopped cooperating. It feels like failure. It usually isn't.

A plateau is your body defending a new, lower set point. As you lose fat, your metabolism slows a bit, your hunger hormones push back, and the same dose that drove rapid early loss now mostly holds the line. That's not the drug quitting on you. In many cases it's the drug doing precisely what it's supposed to do, which is help you maintain a weight your biology would otherwise fight to reverse.

We have good evidence on what happens when people stay the course versus when they don't. In the STEP 4 trial, published in JAMA in 2021 by Rubino and colleagues, participants did a 20-week run-in on semaglutide and then either continued the medication or switched to placebo. The group that kept going lost another roughly eight percent over the next year. The group that stopped regained almost seven percent. That's a swing of nearly fifteen percentage points separating the people who persevered from the people who quit. The plateau, in other words, is often the maintenance phase wearing a disguise.

So when someone tells me they've stalled, my first questions aren't about the medication at all. Are you still hitting your protein target? Are you lifting or doing any resistance work? Are you sleeping? Are you drinking enough water in this Texas heat, because dehydration alone can stall the scale and make you feel awful? More often than not, the plateau breaks with a tune-up to the basics rather than a wholesale change of plan.

When a pivot is the smarter move

Perseverance isn't always the answer, though, and I'd be doing you a disservice if I pretended otherwise. Sometimes the honest read is that the current plan needs to change. A pivot can mean a few different things.

It might mean adjusting the dose. If you've been parked at the same dose for months and the side effects have settled, there may be room to titrate up under supervision. It might mean switching molecules entirely. Some people respond modestly to semaglutide and then lose meaningfully more when they move to tirzepatide, which hits two gut hormone receptors instead of one. The SURMOUNT-4 trial, published in JAMA in 2024 by Aronne and colleagues, showed that people who continued tirzepatide for weight maintenance held onto their loss while those who stopped drifted back up, which tells you the tool is powerful when it's matched to the right person.

A pivot might also mean looking past the medication. If your weight loss has stalled and your energy is in the basement, your libido is gone, and you feel flat, the problem might not be the GLP-1. It might be a thyroid running slow, testosterone that's tanked, or perimenopausal hormone shifts that no appetite suppressant is going to fix. This is exactly why I don't treat weight loss as a standalone service. We run the labs. Sometimes the smartest pivot at the mid-year mark is widening the lens.

And occasionally a pivot means easing off. If you've reached a healthy weight, your labs look great, and you've genuinely rebuilt your eating and movement habits, we can have a thoughtful conversation about tapering. I'd never frame that as "you're done forever." Obesity behaves like a chronic condition, and we manage it like one. But the plan can flex.

The stop question, answered straight

This is the one I get asked most quietly, usually near the end of a visit. "Do I have to be on this forever?" People hate that question because they're afraid of the answer. Let me give it to you straight, because you deserve that more than reassurance.

For most people, stopping cold means regaining a meaningful chunk of what they lost. The STEP 1 trial extension, published by Wilding and colleagues in Diabetes, Obesity and Metabolism in 2022, followed people for a year after semaglutide was withdrawn. On average they regained about two-thirds of the weight they'd lost, and a lot of the metabolic improvements faded right along with it. That isn't a willpower failure. It's biology reasserting a set point the medication was holding in check.

Does that mean nobody can ever stop? No. But it means stopping should be a deliberate, supervised step-down with a real maintenance plan behind it, not a quiet decision to skip the next refill and hope for the best. The people who keep the weight off after stopping are almost always the ones who used their time on the medication to overhaul the foundation underneath it. They built muscle. They learned to eat in a way they can sustain. They fixed their sleep. The drug bought them a window, and they renovated the house while they had it.

If you've done that work, a taper might be reasonable. If you haven't yet, that's not a reason to feel bad. It's just your answer to the pivot-or-persevere question. Persevere, and use the second half of the year to build what you'll need later.

The scale is one data point, not the whole story

Before you grade your six months on the scale alone, widen the rubric. The scale measures the pull of gravity on your entire body, fat and muscle and water all lumped together. It can't tell the difference between losing five pounds of fat and losing five pounds of muscle, and those two outcomes are nothing alike.

This is one of my real worries with GLP-1 medications when they're used without supervision. Rapid weight loss, especially on aggressive doses with low protein intake, can strip away lean muscle alongside the fat. You'll weigh less, the scale will reward you, and you'll quietly be setting yourself up for a slower metabolism and a harder time keeping the weight off down the road. A patient who's "only" down twelve pounds but has held onto muscle and dropped a pant size is in a far better spot than someone down twenty who's lost a chunk of their lean mass.

So at the mid-year mark, look at the things the scale hides. How's your waist measurement? How do your clothes fit? Can you climb the stairs at Southlake Town Square without your knees complaining? Are you stronger in the gym, sleeping better, thinking more clearly? Those non-scale victories are often the truest sign that the plan is working, and they're the ones worth protecting if you're deciding whether to persevere. When the scale stalls but the tape measure keeps shrinking, you're recomposing, and that's a win even if the number on the floor disagrees.

Doing your own mid-year audit

You don't need a degree to run this assessment yourself. Pull your January weight and your June weight and calculate the percentage you've lost. Be honest about the inputs: protein, resistance training, sleep, hydration, alcohol, stress. Notice how you actually feel, not just what the scale says, because energy, mood, and how your clothes fit tell you things a single number can't.

Then ask the real question. Is this plan still working for the person I am right now, in June, with the summer and the rest of the year ahead? If yes, persevere, and tighten up the basics that drive the next phase. If something's genuinely off, pivot, and pivot with data rather than frustration. The worst option, honestly, is the passive drift: half-skipping doses, half-following the plan, and quietly losing ground without ever deciding anything.

If you want a second set of eyes on your numbers, that's a big part of what we do at Magnolia Functional Wellness in Southlake. A mid-year visit is a good time to look at your labs, revisit the goals you set in January, and decide together whether the back half of your year calls for staying the course or changing it. Either way, you'll leave with a plan you actually chose, which beats wandering into July hoping things sort themselves out. If you want to understand the bigger picture of physician-supervised options first, our guide to GLP-1 weight loss in DFW is a solid place to start.

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX